Proprietary, highly efficient and scalable linDNA (linear DNA, the product of PCR) manufacturing process for use in nucleic acid-based therapies. Learn how LineaRx is the common denominator of next-generation therapies.
- JP Morgan 2024 Healthcare Conference – IR & BD Presentation
- White Paper: Next Generation Medicines, The Therapeutic Potential of linearDNA Delivered via Lipid Nanoparticle
- The Future of RNA Therapies Produced with LinearDNA™ IVT Templates
- Overcoming the DNA Bottleneck
- Linear DNA amplicons as a novel cancer vaccine strategy